These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7397054)

  • 41. Inhibition of renin secretion by intrarenal alpha-adrenoceptor blockade.
    Blair ML
    Am J Physiol; 1981 Jun; 240(6):E682-8. PubMed ID: 6264792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prazosin--pharmacology and mechanism of action].
    Starke K
    Ther Umsch; 1981; 38 Suppl():24-7. PubMed ID: 6280329
    [No Abstract]   [Full Text] [Related]  

  • 43. Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers.
    Elliott HL; McLean K; Sumner DJ; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1981 Mar; 29(3):303-9. PubMed ID: 6110503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the renin response to vasoactive intestinal polypeptide (VIP) in the conscious rabbit.
    Calam J; Dimaline R; Peart WS; Unwin R
    Br J Pharmacol; 1983 Sep; 80(1):13-5. PubMed ID: 6140051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of prazosin on cardiac reflex function.
    Hardey DW; Lokhandwala MF
    Eur J Pharmacol; 1979 Aug; 57(2-3):251-4. PubMed ID: 488164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparate effects of prazosin and propranolol on lipid metabolism in a rat model.
    Dall'Aglio E; Chang H; Reaven G
    Metabolism; 1983 May; 32(5):510-3. PubMed ID: 6843362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prazosin in normal subjects: plasma levels, blood pressure and heart rate.
    Wood AJ; Bolli P; Simpson FO
    Br J Clin Pharmacol; 1976 Feb; 3(1):199-201. PubMed ID: 973941
    [No Abstract]   [Full Text] [Related]  

  • 48. The influence of prazosin and propranolol on serum lipids and atherosclerosis in standard fed pigs.
    Helgeland A; Eriksen K; Foss PO; Nafstad I; Solberg LA; Tollersrud S
    Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):270-2. PubMed ID: 6730983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influence of indomethacin and clidanac on the blood pressure lowering effect of beta-blockers].
    Imai H; Niwa M; Nozaki M; Tsurumi K; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):13-20. PubMed ID: 6133820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs.
    Beaulieu G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):283-90. PubMed ID: 3161477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of age on the sensitivity of the alpha 1-adrenoceptor to phenylephrine and prazosin.
    Klein C; Gerber JG; Payne NA; Nies AS
    Clin Pharmacol Ther; 1990 Apr; 47(4):535-9. PubMed ID: 2158407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha adrenergic blockade by prazosin in therapy of essential hypertension.
    Ram CV; Anderson RJ; Hart GR; Crumpler CP
    Clin Pharmacol Ther; 1981 Jun; 29(6):719-22. PubMed ID: 6112091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    Hamilton CA; Reid JL; Vincent J
    Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic effects of prazosin.
    Barbieri C; Caldara R; Ferrari C; Dal Bo GA; Paracchi A; Romussi M; Curtarelli G
    Clin Pharmacol Ther; 1980 Mar; 27(3):313-6. PubMed ID: 6102000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-receptor function changes after the first dose of prazosin.
    von Bahr C; Lindström B; Seideman P
    Clin Pharmacol Ther; 1982 Jul; 32(1):41-7. PubMed ID: 6282526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue distribution and hypotensive effect of prazosin in the conscious rat.
    Dynon MK; Jarrott B; Louis WJ
    J Cardiovasc Pharmacol; 1983; 5(2):235-9. PubMed ID: 6188896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical pharmacology of prazosin in arterial hypertension with chronic renal insufficiency].
    Chaignon M; Le Roux E; Aubert P; Lucsko M; Flouvat B; Guédon J
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():71-7. PubMed ID: 6794530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
    Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA
    Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
    O'Connor DT; Preston RA; Sasso EH
    Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032
    [No Abstract]   [Full Text] [Related]  

  • 60. Prazosin kinetics and effectiveness in renal failure.
    Lowenthal DT; Hobbs D; Affrime MB; Twomey TM; Martinez EW; Onesti G
    Clin Pharmacol Ther; 1980 Jun; 27(6):779-83. PubMed ID: 7379445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.